Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Chang

Showing results (101-110 of 119) with videos related to

Pageof 12
Sort By:
Journal of Neurology|December 19, 2019
Optimization of risk stratification for anticoagulation-associated intracerebral hemorrhage: net risk estimationVasileios-Arsenios Lioutas, Nitin Goyal, Aristeidis H Katsanos, et al.
Stroke|October 26, 2018
Clinical Outcomes and Neuroimaging Profiles in Nondisabled Patients With Anticoagulant-Related Intracerebral HemorrhageVasileios-Arsenios Lioutas, Nitin Goyal, Aristeidis H Katsanos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 26, 2020
The Genomic Landscape of <i>SMARCA4</i> Alterations and Associations with Outcomes in Patients with Lung CancerAdam J Schoenfeld, Chai Bandlamudi, Jessica A Lavery, et al.
Hepatology (Baltimore, Md.)|February 21, 2024
Full adherence to cirrhosis quality indicators is associated with lower mortality in acute variceal bleeding: Nationwide auditYu Jun Wong, Margaret Teng, Alyssa Sim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 11, 2020
<i>MET</i> Exon 14-altered Lung Cancers and MET Inhibitor ResistanceRobin Guo, Michael Offin, A Rose Brannon, et al.
Alimentary Pharmacology & Therapeutics|November 7, 2020
Comparative biomarkers for HBsAg loss with antiviral therapy shows dominant influence of quantitative HBsAg (qHBsAg)Seng Gee Lim, Wah Wah Phyo, Joanna Zhi Jie Ling, et al.
Cancer Discovery|April 4, 2018
Response to ERBB3-Directed Targeted Therapy in <i>NRG1</i>-Rearranged CancersAlexander Drilon, Romel Somwar, Biju P Mangatt, et al.
Clinical and Translational Medicine|May 29, 2025
Responsiveness of different MET tumour alterations to type I and type II MET inhibitorsYonina R Murciano-Goroff, Valentina Foglizzo, Jason Chang, et al.
Antiviral Research|April 19, 2024
Quantitative HBeAg is a strong predictor of HBeAg loss among patients receiving pegylated interferonDaniel Q Huang, Liang Shen, Wah Wah Phyo, et al.
Neurology|August 18, 2017
Direct oral anticoagulant- vs vitamin K antagonist-related nontraumatic intracerebral hemorrhageGeorgios Tsivgoulis, Vasileios-Arsenios Lioutas, Panayiotis Varelas, et al.
Pageof 12

Showing results (101-110 of 119) with videos related to

Sort By:
Pageof 12
Journal of Neurology|December 19, 2019
Optimization of risk stratification for anticoagulation-associated intracerebral hemorrhage: net risk estimationVasileios-Arsenios Lioutas, Nitin Goyal, Aristeidis H Katsanos, et al.
Stroke|October 26, 2018
Clinical Outcomes and Neuroimaging Profiles in Nondisabled Patients With Anticoagulant-Related Intracerebral HemorrhageVasileios-Arsenios Lioutas, Nitin Goyal, Aristeidis H Katsanos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 26, 2020
The Genomic Landscape of <i>SMARCA4</i> Alterations and Associations with Outcomes in Patients with Lung CancerAdam J Schoenfeld, Chai Bandlamudi, Jessica A Lavery, et al.
Hepatology (Baltimore, Md.)|February 21, 2024
Full adherence to cirrhosis quality indicators is associated with lower mortality in acute variceal bleeding: Nationwide auditYu Jun Wong, Margaret Teng, Alyssa Sim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 11, 2020
<i>MET</i> Exon 14-altered Lung Cancers and MET Inhibitor ResistanceRobin Guo, Michael Offin, A Rose Brannon, et al.
Alimentary Pharmacology & Therapeutics|November 7, 2020
Comparative biomarkers for HBsAg loss with antiviral therapy shows dominant influence of quantitative HBsAg (qHBsAg)Seng Gee Lim, Wah Wah Phyo, Joanna Zhi Jie Ling, et al.
Cancer Discovery|April 4, 2018
Response to ERBB3-Directed Targeted Therapy in <i>NRG1</i>-Rearranged CancersAlexander Drilon, Romel Somwar, Biju P Mangatt, et al.
Clinical and Translational Medicine|May 29, 2025
Responsiveness of different MET tumour alterations to type I and type II MET inhibitorsYonina R Murciano-Goroff, Valentina Foglizzo, Jason Chang, et al.
Antiviral Research|April 19, 2024
Quantitative HBeAg is a strong predictor of HBeAg loss among patients receiving pegylated interferonDaniel Q Huang, Liang Shen, Wah Wah Phyo, et al.
Neurology|August 18, 2017
Direct oral anticoagulant- vs vitamin K antagonist-related nontraumatic intracerebral hemorrhageGeorgios Tsivgoulis, Vasileios-Arsenios Lioutas, Panayiotis Varelas, et al.
Pageof 12